bullish

Stan

Stan: The $14.7M/year store-in-bio

110 Views01 Feb 2024 08:00
TL;DR: Stan hit $14.7M of annual recurring revenue (ARR) at the end of 2023, up 765% year-over-year, as store-in-bio replaced link-in-bio as the default home base of the online creator. Now, Stan is looking to overtake incumbent link-in-bio platform Linktree ($49M ARR, up 46% year-over-year) while getting on a trajectory to improve their 13% monthly gross churn. For more, check out our coverage of Stan (dataset) and Linktree (dataset)...
What is covered in the Full Insight:
  • Introduction
  • Revenue Growth Analysis
  • Competitor Comparison
  • Churn and Risks
  • Affiliate Strategy and Future Outlook
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Stan: The $14.7M/year store-in-bio
    01 Feb 2024
x